本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vera Therapeutics, Inc.

21.81
-0.0700-0.32%
盘后21.810.00000.00%19:37 EDT
成交量:94.64万
成交额:2,051.22万
市值:13.91亿
市盈率:-7.27
高:21.82
开:21.75
低:21.42
收:21.88
数据加载中...
2025/06/03

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/19

重要事件披露

Form 8-K - Current report
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]